OPS
AERI

Orion Portfolio Solutions’s Aerie Pharmaceuticals AERI Stock Holding History

Orion Portfolio Solutions’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-12
Closed – – 2536
2020
Q1 		$0 Sell
12
-46
-79% -$873 ﹤0.01% 2417
2019
Q4 		$1K Buy
+58
New +$1.2K ﹤0.01% 1767

Other funds holding AERI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Orion Portfolio Solutions's AERI Position: Q2 2020 in Review

Orion Portfolio Solutions sold out of Aerie Pharmaceuticals (AERI) in Q2 2020, closing a stake of 12 shares.

Orion Portfolio Solutions first reported a position in AERI in Q4 2019 and held it in 2 quarters. The position peaked at $1K in Q4 2019. 155 funds tracked by Wall St. Rank hold AERI as of Q2 2020.

  • Orion Portfolio Solutions reported no remaining Aerie Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Orion Portfolio Solutions sold 12 Aerie Pharmaceuticals shares in Q2 2020.
  • Orion Portfolio Solutions first reported a position in Aerie Pharmaceuticals in Q4 2019 and held it in 2 quarters.
  • Orion Portfolio Solutions's Aerie Pharmaceuticals position peaked at $1K in Q4 2019.
  • 155 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q2 2020.

Based on Orion Portfolio Solutions's 13F filing for Q2 2020, filed 13 Aug 2020.